ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,979,019 | +122.8% | 1,663,041 | +236.9% | 0.00% | – |
| Q1 2024 | $888,428 | +131.4% | 493,571 | +13.1% | 0.00% | – |
| Q4 2023 | $383,918 | +19.5% | 436,271 | 0.0% | 0.00% | – |
| Q3 2023 | $321,314 | -41.5% | 436,271 | 0.0% | 0.00% | – |
| Q2 2023 | $549,701 | +57.7% | 436,271 | -9.3% | 0.00% | – |
| Q1 2023 | $348,673 | -31.4% | 480,995 | -50.0% | 0.00% | – |
| Q4 2022 | $508,412 | +26.8% | 961,990 | +100.0% | 0.00% | – |
| Q3 2022 | $401,000 | -23.5% | 480,995 | 0.0% | 0.00% | – |
| Q2 2022 | $524,000 | -81.2% | 480,995 | -78.5% | 0.00% | – |
| Q1 2022 | $2,791,000 | -18.6% | 2,233,010 | +4.2% | 0.00% | – |
| Q4 2021 | $3,427,000 | -51.0% | 2,142,050 | -0.2% | 0.00% | – |
| Q3 2021 | $6,996,000 | -45.5% | 2,145,952 | +5.6% | 0.00% | -100.0% |
| Q2 2021 | $12,846,000 | – | 2,032,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 524,805 | $572,000 | 0.39% |
| Laurion Capital Management LP | 2,225,800 | $2,426,000 | 0.04% |
| Ergoteles LLC | 514,600 | $561,000 | 0.02% |
| Pinz Capital Management, LP | 17,900 | $20,000 | 0.01% |
| Alpine Global Management, LLC | 37,089 | $40,000 | 0.01% |
| Game Plan Financial Advisors, LLC | 10,000 | $11,000 | 0.01% |
| Spire Wealth Management | 100,300 | $109,000 | 0.00% |
| Renaissance Technologies | 1,989,995 | $2,169,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,279,636 | $2,485,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 16,912 | $18,000 | 0.00% |